itis. Our observation suggests that acetaldehyde, in concentrations 3-4 times higher than the usual level in
tion in both bottles. Gram stains from all patients and proven report of any acute or chronic side-effects that cultures revealed no micro-organisms. In 14 patients, empiric may be directly linked to glucose breakdown products.
antibiotic treatment was started (Table 1 ). The number of This report of 21 chemical peritonitis cases may be the patients with signs of peritonitis was unexpectedly high first clinical evidence that glucose degradation products compared with our centre's peritonitis record (one episode/26 may cause serious acute side-effects in chronic PD months by that time). It was remarkable that peritonitis patients.
signs were evident only in patients using bags with lot number M710154 with expiry dates of 2000-9. Patients using imported bags and domestic bags with other lot numbers
Subjects and methods
were symptom free. Additionally, PD fluid in bags with the M710154 lot number appeared darker than usual. After a few days, our suspicion of an aseptic peritonitis induced by This observation was carried out between 15 October 1996 one or more chemicals in the PD fluid was strong enough to and 18 November 1996. All 21 end-stage renal failure patients justify holding antibiotic therapy in all patients. Patients in this report (nine female, 12 male; mean age 48±12 years)
continued PD with bags of another lot number and antihad been on continuous ambulatory PD (CAPD) treatment biotics were stopped on 23 October 1996 in 10 patients. In under medical supervision at Akdeniz University Medical four patients antibiotics were stopped later because of comSchool, Department of Medicine, Division of Nephrology, munication problems. In seven patients, antibiotics were Peritoneal Dialysis Unit. CAPD was performed with a never started because of strong evidence for a chemical double-bag disconnect PD system. Principal characteristics aetiology ( Table 1 ). The PD bag manufacturer was immediof the patients are shown in Table 1 . Among 55 CAPD ately informed of the problem and fluid samples from lot patients who had been followed by our PD outpatient clinic M710154 were taken. Because of yellow-brownish discoloraby that time, all 21 presented with signs and symptoms of tion of the fluid, which was highly suspicious of increased peritonitis, including cloudy dialysate, abdominal tenderness glucose degradation during heat sterilization, pH and acetalwith additional abdominal pain in 11 patients, and vomiting dehyde levels were investigated in the PD fluid with the lot in one. Fifteen episodes accumulated during the week of number M710154. 18-25 October 1996. Their CAPD regimen was four 2-l exchanges with 1.36/2.27/1.36/3.86% dextrose concentrations in 13 patients, 1.36/2.27/2.27/3.86% dextrose concentrations in four patients, 2.27/2.27/2.27/3.86% dextrose concentra-Results tions in two patients, and 2.27/3.86/2.27/3.86% dextrose ( Table 1) . In all patients, all peri-USA). Samples were incubated in an automatic blood culture system and bacterial growth was detected with CO 2 produc-toneal symptoms resolved within 24 h following 
tonitis epidemic in the cases presented above. unused PD solution samples from lot M710154 revealed very high levels of acetaldehyde (17, 17, 19 Following feedback from our hospital, procedural changes were made in the newly established production and 20 p.p.m.), compared with a standard average of 6 p.p.m. in bags that had no brownish discoloration line and no similar problems have occurred since.
Although it is not clear which particular glucose and caused no patient complaints. Acetaldehyde concentrations measured by company analysis in bags degradation product is responsible for their cytotoxic effects [12] , it is well known that glucose degradation with lot number M710154 was also between 17 and 20 p.p.m. In all bags, pH was 5.9. products in commercially available PD solutions may contribute to peritoneal membrane injury as evidenced Based on the above results, and in order to avoid further patient complaints originating from increased by their in vitro effects such as impairing mouse fibroblast cellular growth and altering inflammatory glucose degradation products in the fluids, the manufacturer reviewed its heat sterilization process in the response [20] . There is only limited clinical evidence to prove that any glucose degradation product has production line and reportedly stopped the use of pH 5.9 -lactate and replaced it with pH 5.3 -lactate. induced PD fluid side-effects in human beings, including reversible loss of ultrafiltration and abdominal pain Following that revision in the heat sterilization process, acetaldehyde concentrations in the bags were below 6 induced by PD bags towards the end of their shelf life [14, 15] . The findings and observations given above p.p.m., no visible discoloration of the fluid was observed, and no further unusual patient complaints may be the first clinical evidence that acetaldehyde and possibly other glucose degradation products, in conoccurred during the use of locally produced PD fluids in Turkey.
centrations 3-4 times higher than usual in commercial PD bags, may induce acute, chemical peritonitis. If so, the long-term effects of glucose degradation products
Discussion
in commercial PD solutions should be cautiously investigated. We have presented 21 patients with mild to moderate symptoms of PD-related peritonitis. Evidence such as
References
negative Gram stain and cultures, sudden, episodic onset in a very large patient population using bags
